Distinct distribution of corticotropin releasing factor receptors in human breast cancer

Neuropeptides

Volumn 44, Issue 5, 2010, Pages 355-361

  Kaprara, A ^a   Pazaitou Panayiotou, K ^a   Chemonidou, M C ^b   Constantinidis, T C ^b   Lambropoulou, M ^b   Koffa, M ^b   Kiziridou, A ^a   Kakolyris, S ^b   Kortsaris, A ^b   Chatzaki, E ^b  

^a Anticancer Hospital 'Theagenio'   (Greece)

^b DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

Author keywords

Breast; Cancer; Corticotropin releasing hormone; Human; Receptor; Urocortin

Indexed keywords

CORTICOTROPIN RELEASING FACTOR RECEPTOR 1; CORTICOTROPIN RELEASING FACTOR RECEPTOR 2; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; ARTICLE; BREAST ADENOCARCINOMA; BREAST BIOPSY; BREAST DUCT; CANCER INVASION; CORRELATION ANALYSIS; GENE MAPPING; GENETIC TRANSCRIPTION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LYMPH NODE METASTASIS; PRIMARY TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; STATISTICAL SIGNIFICANCE;

ADENOCARCINOMA; BREAST; BREAST NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STATISTICS, NONPARAMETRIC;

EID: 77956189718     PISSN: 01434179     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.npep.2010.06.005     Document Type: Article

References (32)

1. Androulidaki A., Dermitzaki E., Venihaki M., Karagianni E., Rassouli O., Andreakou E., Stournaras C., Margioris A.N., Tsatsanis C. Corticotropin releasing factor promotes breast cancer cell motility and invasiveness. Mol. Cancer 2009, 8:30.
2. Arbiser J.L., Karalis K., Viswanathan A., Koike C., Anand-Apte B., Flynn E., Zetter B., Majzoub J.A. Corticotropin-releasing hormone stimulates angiogenesis and epithelial tumor growth in the skin. J. Invest. Dermatol. 1999, 113:838-842.
3. Baigent S.M. Peripheral corticotropin-releasing hormone and urocortin in the control of the immune response. Peptides 2001, 22:809-820.
4. Bale T.L., Vale W.W. CRF and CRF receptors: role in stress responsivity and other behaviors. Annu. Rev. Pharmacol. Toxicol. 2004, 44:525-557.
5. Brar B.K., Stephanou A., Okosi A., Lawrence K.M., Knight R.A., Marber M.S., Latchman D.S. CRH-like peptides protect cardiac myocytes from lethal ischaemic injury. Mol. Cell. Endocrinol. 1999, 158:55-63.
6. Chatzaki E., Charalampopoulos I., Leontidis C., Mouzas I.A., Tzardi M., Tsatsanis C., Margioris A.N., Gravanis A. Urocortin in human gastric mucosa: relationship to inflammatory activity. J. Clin. Endocrinol. Metab. 2003, 88:478-483.
7. Chatzaki E., Crowe P.D., Wang L., Million M., Tache Y., Grigoriadis D.E. CRF receptor type 1 and 2 expression and anatomical distribution in the rat colon. J. Neurochem. 2004, 90:309-316.
8. Chatzaki E., Murphy B.J., Wang L., Million M., Ohning G.V., Crowe P.D., Petroski R., Tache Y., Grigoriadis D.E. Differential profile of CRF receptor distribution in the rat stomach and duodenum assessed by newly developed CRF receptor antibodies. J. Neurochem. 2004, 88:1-11.
9. Chatzaki E., Euthymiadis C., Kyriaki S., Lambropoulou M., Tsaroucha A., Laftsidis P., Simopoulos K. Urocortin and corticotropin-releasing hormone receptor type 2 expression in the human gallbladder. Neuroendocrinology 2005, 82:177-184.
10. Chatzaki E., Lambropoulou M., Constantinidis T.C., Papadopoulos N., Tache Y., Minopoulos G., Grigoriadis D.E. Corticotropin-releasing factor (CRF) receptor type 2 in the human stomach: protective biological role by inhibition of apoptosis. J. Cell Physiol. 2006, 209:905-911.
11. Chen R., Lewis K.A., Perrin M.H., Vale W.W. Expression cloning of a human corticotropin-releasing-factor receptor. Proc. Natl. Acad. Sci. USA 1993, 90:8967-8971.
12. Ciocca D.R., Puy L.A., Fasoli L.C., Tello O., Aznar J.C., Gago F.E., Papa S.I., Sonego R. Corticotropin-releasing hormone, luteinizing hormone-releasing hormone, growth hormone-releasing hormone, and somatostatin-like immunoreactivities in biopsies from breast cancer patients. Breast Cancer Res. Treat. 1990, 15:175-184.
13. Florio P., De Falco G., Leucci E., Torricelli M., Torres P.B., Toti P., Dell'Anna A., Tiso E., Santopietro R., Leoncini L., Petraglia F. Urocortin expression is downregulated in human endometrial carcinoma. J. Endocrinol. 2006, 190:99-105.
14. Graziani G., Tentori L., Muzi A., Vergati M., Tringali G., Pozzoli G., Navarra P. Evidence that corticotropin-releasing hormone inhibits cell growth of human breast cancer cells via the activation of CRH-R1 receptor subtype. Mol. Cell Endocrinol. 2007, 264:44-49.
15. Graziani G., Tentori L., Portarena I., Barbarino M., Tringali G., Pozzoli G., Navarra P. CRH inhibits cell growth of human endometrial adenocarcinoma cells via CRH-receptor 1-mediated activation of cAMP-PKA pathway. Endocrinology 2002, 143:807-813.
16. Grino M., Chrousos G.P., Margioris A.N. The corticotropin releasing hormone gene is expressed in human placenta. Biochem. Biophys. Res. Commun. 1987, 148:1208-1214.
17. Imperatore A., Florio P., Torres P.B., Torricelli M., Galleri L., Toti P., Occhini R., Picciolini E., Vale W., Petraglia F. Urocortin 2 and urocortin 3 are expressed by the human placenta, deciduas, and fetal membranes. Am. J. Obstet. Gynecol. 2006, 195:288-295.
18. Kaprara, A., Pazaitou-Panayiotou, K., Kortsaris, A., Chatzaki, E., 2010. The corticotropin releasing factor system in cancer: expression and pathophysiological implications. Cell Mol. Life Sci.
19. Kostich W.A., Chen A., Sperle K., Largent B.L. Molecular identification and analysis of a novel human corticotropin-releasing factor (CRF) receptor: the CRF2gamma receptor. Mol. Endocrinol. 1998, 12:1077-1085.
20. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25:402-408.
21. Lovenberg T.W., Liaw C.W., Grigoriadis D.E., Clevenger W., Chalmers D.T., De Souza E.B., Oltersdorf T. Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain [published erratum appears in Proc. Natl. Acad. Sci. USA 1995 Jun 6, 92 (12), 5759]. Proc. Natl. Acad. Sci. USA 1995, 92:836-840.
22. Makrigiannakis A., Margioris A.N., Le Goascogne C., Zoumakis E., Nikas G., Stournaras C., Psychoyos A., Gravanis A. Corticotropin-releasing hormone (CRH) is expressed at the implantation sites of early pregnant rat uterus. Life Sci. 1995, 57:1869-1875.
23. Miceli F., Ranelletti F.O., Martinelli E., Petrillo M., Scambia G., Navarra P., Ferrandina G. Expression and subcellular localization of CRH and its receptors in human endometrial cancer. Mol. Cell Endocrinol. 2009, 305:6-11.
24. Minas V., Rolaki A., Kalantaridou S.N., Sidiropoulos J., Mitrou S., Petsas G., Jeschke U., Paraskevaidis E.A., Fountzilas G., Chrousos G.P. Intratumoral CRH modulates immuno-escape of ovarian cancer cells through FasL regulation. Br. J. Cancer 2007, 97:637-645.
25. Muramatsu Y., Fukushima K., Iino K., Totsune K., Takahashi K., Suzuki T., Hirasawa G., Takeyama J., Ito M., Nose M. Urocortin and corticotropin-releasing factor receptor expression in the human colonic mucosa. Peptides 2000, 21:1799-1809.
26. Nagashima H., Asakura M., Hishinuma T., Tanaka D., Fujii S. Reduction and sensitization of CRH neuron in rat hypothalamic and extrahypothalamic regions after chronic variable stress. Nihon Shinkei Seishin Yakurigaku Zasshi 2003, 23:21-28.
27. Reubi J.C., Waser B., Vale W., Rivier J. Expression of CRF1 and CRF2 receptors in human cancers. J. Clin. Endocrinol. Metab. 2003, 88:3312-3320.
28. Simopoulos C., Christodoulou E., Lambropoulou M., Tsaroucha A.K., Kakolyris S., Polychronidis A., Karayiannakis A.J., Chatzaki E. Neuropeptide urocortin 1 and its receptors are expressed in the human liver. Neuroendocrinology 2008.
29. Simopoulos C., Christodoulou E., Lambropoulou M., Tsaroucha A.K., Kakolyris S., Polychronidis A., Karayiannakis A.J., Chatzaki E. Neuropeptide urocortin 1 and its receptors are expressed in the human liver. Neuroendocrinology 2009, 89:315-326.
30. Tjuvajev J., Kolesnikov Y., Joshi R., Sherinski J., Koutcher L., Zhou Y., Matei C., Koutcher J., Kreek M.J., Blasberg R. Anti-neoplastic properties of human corticotropin releasing factor: involvement of the nitric oxide pathway. In Vivo 1998, 12:1-10.
31. Vale W., Spiess J., Rivier C., Rivier J. Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin. Science 1981, 213:1394-1397.
32. Zoumakis E., Chatzaki E., Charalampopoulos I., Margioris A.N., Angelakis E., Koumantakis E., Gravanis A. Cycle and age-related changes in corticotropin-releasing hormone levels in human endometrium and ovaries. Gynecol. Endocrinol. 2001, 15:98-102.